Please login to the form below

Not currently logged in
Email:
Password:

Pierre Fabre

This page shows the latest Pierre Fabre news and features for those working in and with pharma, biotech and healthcare.

UK pharma Code of Practice to change with digital times

UK pharma Code of Practice to change with digital times

Earlier this year, Martindale Pharma, Pierre Fabre, Janssen and Pharmasure were all named in adverts following serious breaches the Code.

Latest news

  • Alnylam’s amyloidosis drug heads latest crop of CHMP approvals Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

    It also backed three targeted cancer drugs: Pierre Fabre’s BRAF inhibitor Braftovi (encorafenib) and MEK inhibitor Mektovi (binimetinib) as a combination for BRAF V600-positive melanoma; and Eli Lilly’s

  • A unique ecosystem A unique ecosystem

    Medicen has seen very positive results in 2016, with 20% business growth and the arrival of 80 new members, including mid-size pharma company Pierre Fabre.

  • Cancer pain: opioids set to dominate Cancer pain: opioids set to dominate

    In clinical trials, dexmedetomidine was well tolerated. Pierre Fabre is developing befiradol, a selective serotonin-1A receptor agonist, for the treatment of chronic pain.

  • AZ and Redx collaborate on genetics of cancer AZ and Redx collaborate on genetics of cancer

    As for Redx, the company has interests in both oncology and in infectious diseases and has an existing cancer collaboration with Pierre Fabre Laboratories.

  • FDA approves AZ’s fish oil drug FDA approves AZ’s fish oil drug

    Omacor/Lovaza achieved end-user sales of around $1.4bn in 2011 and is sold by Abbott Laboratories in the US and various companies including GlaxoSmithKline, Grupo Ferrer and Pierre Fabre

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics